Roivant Sciences (ROIV) Operating Expenses (2020 - 2025)

Roivant Sciences' Operating Expenses history runs 6 years deep, the most recent figure standing at $936.0 million for Q4 2025.

• Quarterly Operating Expenses rose 10.1% year-over-year to $936.0 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $1.5 billion (up 8.04% YoY) and the FY2026 annual result came in at $1.3 billion, up 13.2% from the prior year.
• Operating Expenses was $936.0 million for Q4 2025 at Roivant Sciences, up from $307.8 million in the prior quarter.
• Across five years, Operating Expenses topped out at $1.1 billion in Q4 2021 and bottomed at $162.1 million in Q2 2021.
• A 5-year average of $511.9 million and a median of $307.8 million in 2025 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2021 — Operating Expenses jumped 342.42% — and 2022, when it sank 58.01%.
• Roivant Sciences' Operating Expenses stood at $1.1 billion in 2021, then fell by 13.78% to $975.1 million in 2022, then slumped by 31.47% to $668.2 million in 2023, then rose by 27.23% to $850.2 million in 2024, then advanced by 10.1% to $936.0 million in 2025.
• Business Quant data shows ROIV's Operating Expenses at $936.0 million in Q4 2025, $307.8 million in Q3 2025, and $287.1 million in Q2 2025.